Literature DB >> 11032726

E-73, an acetoxyl analogue of cycloheximide, blocks the tumor necrosis factor-induced NF-kappaB signaling pathway.

H Sugimoto1, T Kataoka, M Igarashi, M Hamada, T Takeuchi, K Nagai.   

Abstract

Proinflammatory cytokines such as tumor necrosis factor (TNF) and interleukin (IL)-1 activate the NF-kappaB signaling pathway which induces the expression of a variety of genes such as the encoding intercellular adhesion molecule (ICAM)-1. We have found that E-73, an acetoxyl analogue of cycloheximide, specifically blocks TNF-induced ICAM-1 expression even at concentrations unable to affect protein synthesis. By contrast, cycloheximide inhibited both TNF- and IL-1-induced ICAM-1 expression primarily due to the blockage of protein synthesis. The nuclear translocation of NF-kappaB as well as the IkappaB degradation induced by TNF, but not by IL-1, was significantly prevented by E-73. These observations suggest that E-73 blocks the TNF-induced NF-kappaB signaling pathway upstream of IkappaB degradation. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11032726     DOI: 10.1006/bbrc.2000.3680

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Irciniastatin A, a pederin-type translation inhibitor, promotes ectodomain shedding of cell-surface tumor necrosis factor receptor 1.

Authors:  Seiya Hirano; Hue Tu Quach; Tsubasa Watanabe; Naoki Kanoh; Yoshiharu Iwabuchi; Takeo Usui; Takao Kataoka
Journal:  J Antibiot (Tokyo)       Date:  2015-01-28       Impact factor: 2.649

2.  Clinical and pathological features of Nerium oleander extract toxicosis in wistar rats.

Authors:  Tasleem Akhtar; Nadeem Sheikh; Muddasir Hassan Abbasi
Journal:  BMC Res Notes       Date:  2014-12-23

Review 3.  Ribosomal alteration-derived signals for cytokine induction in mucosal and systemic inflammation: noncanonical pathways by ribosomal inactivation.

Authors:  Yuseok Moon
Journal:  Mediators Inflamm       Date:  2014-01-02       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.